⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29613801 | 0.93 | NT5E (0.33) | — | |
| SCHEMBL29613863 | 0.93 | NT5E (0.33) | — | |
| SCHEMBL22899496 | 0.93 | NT5E (0.33) | — | |
| SCHEMBL29613898 | 0.91 | — | — | |
| SCHEMBL29613865 | 0.91 | — | — | |
| SCHEMBL29613894 | 0.91 | — | — | |
| SCHEMBL29613823 | 0.90 | — | — | |
| SCHEMBL29613862 | 0.90 | — | — | |
| SCHEMBL29613886 | 0.88 | — | — | |
| SCHEMBL29613845 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12544391-B2 | CD73 inhibitors | ORIC PHARMACEUTICALS, INC. (US) | 2026-02-10 | — | — | US | disclosed |
| US-20220331343-A1 | CD73 INHIBITORS | ORIC PHARMACEUTICALS, INC. | 2022-10-20 | — | — | US | disclosed |
| EP-3999517-A1 | CD73 INHIBITORS | Oric Pharmaceuticals, Inc. (US) | 2022-05-25 | — | — | EP | disclosed |